Archives: Agenda

• Exploring how geopolitics influences clinical trials, from trade policies to international relations
• Discussing the impact of political changes and potential policy shifts
• Analyzing regulatory landscapes and incentives in alternative regions
• Addressing risk factors and strategic decision-making for trial site selection
• Examining the role of ERCs and strategy departments in navigating global shifts

• Identification of critical bottlenecks in multi-country biotech trials and practical methods to resolve them
• Optimisation of project management strategies to accelerate start-up and study conduct without compromising compliance and quality
• Enhancement of collaboration and leveraging of local expertise to ensure quality and timely delivery in European studies

• How AI optimizes clinical trial protocols to reduce errors, streamline processes, and enhance data quality
• A Real-world case study of reduced timelines and improved trial outcomes using Biorce’s platform
• Insights into leveraging predictive analytics for trial success

• Reducing recruitment timelines while improving enrollment success rates
• Integrating AI with electronic health records (EHR) and real-world data
• Overcoming ethical and regulatory challenges in AI-powered recruitment

TBD – Piotr Maślak

• Showcasing a real-world use case that explores the future potential of GenAI in clinical trial operations
• Optimizing trial efficiency and reducing costs through targeted applications of GenAI
• Inspiring long-term thinking on the strategic business impact of integrating GenAI into clinical development processes

Moderator
Sonnika Lamont, Senior Analyst, GlobalData